These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9568994

  • 1. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
    Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
    [Abstract] [Full Text] [Related]

  • 2. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T, Tateda K, Furuya N, Miyazaki S, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [Abstract] [Full Text] [Related]

  • 3. Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa.
    Matsumoto T, Furuya N, Tateda K, Miyazaki S, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    J Med Microbiol; 1999 Aug; 48(8):765-770. PubMed ID: 10451000
    [Abstract] [Full Text] [Related]

  • 4. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
    Gilleland HE, Gilleland LB, Fowler MR.
    J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
    [Abstract] [Full Text] [Related]

  • 5. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M, Kubota Y, Matsuura M, Homma JY.
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract] [Full Text] [Related]

  • 6. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY, Tanimoto H.
    Antibiot Chemother (1971); 1987 Nov; 39():215-21. PubMed ID: 3118783
    [No Abstract] [Full Text] [Related]

  • 7. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
    Cryz SJ, Fürer E, Germanier R.
    Infect Immun; 1983 Mar; 39(3):1072-9. PubMed ID: 6404817
    [Abstract] [Full Text] [Related]

  • 8. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A, Kohanteb J, Mehrabani D, Japoni A, Amini M, Naghmachi M, Zaghi AH, Khalili N.
    BMC Microbiol; 2009 Feb 01; 9():23. PubMed ID: 19183501
    [Abstract] [Full Text] [Related]

  • 9. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization.
    Martinez D, Callahan LT.
    Eur J Clin Microbiol; 1985 Apr 01; 4(2):186-9. PubMed ID: 3924606
    [Abstract] [Full Text] [Related]

  • 10. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.
    Granström M, Ericsson A, Strandvik B, Wretlind B, Pavlovskis OR, Berka R, Vasil ML.
    Acta Paediatr Scand; 1984 Nov 01; 73(6):772-7. PubMed ID: 6441448
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
    Schaad UB, Lang AB, Wedgwood J, Ruedeberg A, Que JU, Fürer E, Cryz SJ.
    Lancet; 1991 Nov 16; 338(8777):1236-7. PubMed ID: 1682645
    [Abstract] [Full Text] [Related]

  • 12. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R.
    Antibiot Chemother (1971); 1987 Nov 16; 39():249-55. PubMed ID: 3118786
    [No Abstract] [Full Text] [Related]

  • 13. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M, Kubota Y, Matsuura M, Homma JY.
    Kitasato Arch Exp Med; 1988 Sep 16; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract] [Full Text] [Related]

  • 14. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB.
    Hum Vaccin; 2007 Sep 16; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract] [Full Text] [Related]

  • 15. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM.
    JAMA; 2002 Jun 12; 287(22):2958-67. PubMed ID: 12052125
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
    Trancassini M, De Vito D, Quattrucci S, Cipriani P.
    New Microbiol; 1999 Apr 12; 22(2):85-9. PubMed ID: 10322606
    [Abstract] [Full Text] [Related]

  • 17. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa].
    Steuhl KP, Döring G, Thiel HJ.
    Fortschr Ophthalmol; 1989 Apr 12; 86(4):283-6. PubMed ID: 2507425
    [Abstract] [Full Text] [Related]

  • 18. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA.
    Can J Microbiol; 1985 Apr 12; 31(4):393-402. PubMed ID: 3924388
    [No Abstract] [Full Text] [Related]

  • 19. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
    Homma JY, Tanimoto H.
    Kitasato Arch Exp Med; 1988 Sep 12; 61(2-3):81-93. PubMed ID: 3145353
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
    Chen TY, Shang HF, Chen TL, Lin CP, Hui CF, Hwang J.
    Appl Microbiol Biotechnol; 1999 Oct 12; 52(4):524-33. PubMed ID: 10570800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.